Low 25-hydroxyvitamin d does not affect insulin sensitivity in obesity after bariatric surgery

Obesity Research

Volumn 13, Issue 10, 2005, Pages 1692-1700

  Manco, Melania ^a,b   Calvani, Menotti ^a   Nanni, Giuseppe ^b   Greco, Aldo V ^a   Iaconelli, Amerigo ^b   Gasbarrini, Giovanni ^a   Castagneto, Marco ^b   Mingrone, Geltrude ^a  

^a Departments of Internal Medicine   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

25 hydroxyvitamin D; Biliopancreatic diversion; Hypovitaminosis D; Insulin resistance; Parathormone

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; GLUCOSE; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; INSULIN RESISTANCE; METABOLISM; OBESITY; WEIGHT REDUCTION;

ADULT; BARIATRICS; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; OBESITY; PARATHYROID HORMONE; VITAMIN D;

EID: 33644802218     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.207     Document Type: Article

References (61)

1. DeLuca HF. The metabolism, physiology and function of vitamin D. In: Kumar R, ed. Vitamin D, Basic and Clinical Aspects. Boston, MA: Nijhoff Publishing; 1984, pp. 259-302.
2. Holick MF. Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone. 1995;17:107-11S.
3. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805-6.
4. Compston JE, Vedi S, Ledger JE, Webba, Gazet JC, Pilkington RE. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981;34:2359-63.
5. Buffington C, Walker B, Cowan GS Jr, Scruggs D. Vitamin D deficiency in morbidly obese. Obes Surg. 1993;3:421-4.
6. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D endocrine system in obese subjects. J Clin Invest. 1985;76:370-3.
7. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43:199-201.
8. Teitelbaum SL, Halverson JD, Bates M, Wise L, Haddad JG. Abnormalities of circulating 25-OH vitamin D after jejunal bypass for obesity: evidence of an adaptive response. Ann Intern Med. 1977;86:289-93.
9. Rickers H, Christiansen C, Balsev I, Rodbro P. Impairment of vitamin D metabolism and bone mineral content after intestinal bypass surgery. Scand J Gasteroenterol. 1984;19:184-9.
10. Hey H, Stockholm KH, Lund BJ, Sorenson OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes. 1982;6:473-9.
11. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol. 1993;129:393-8.
12. Bell NH, Shaw S, Turner RT. Evidence that 1, 25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984;74:1540-4.
13. Worstman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-3.
14. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88:157-61.
15. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89: 1196-9.
16. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820-5.
17. McCarty MF. Dairy products and insulin resistance. JAMA. 2002;288:693.
18. Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002;288:693-4.
19. Pietschmann P, Schernthaner G, Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia. 1988;31:892-5.
20. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995;27:181-8.
21. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24:1496.
22. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome "X"? Br J Nutr. 1998;79:315-27.
23. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia. 1997;40:344-7.
24. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66:618-20.
25. Mingrone G, DeGaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia. 1997;40:599-605.
26. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002;51:1-8.
27. Newbury L, Dolan K, Hatzifptis M, Low N, Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg. 2003;13:893-5.
28. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48-55.
29. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
30. Moore FD, Olesen KH, McMurrey JD, Parker HV, Ball MR, Boyden CM. The Body Cell Mass and Its Supporting Environment. Philadelphia, PA: WB Saunders; 1963.
31. Culebras JM, Fitzpatrick GF, Brennan MF, Boyden CM, Moore FD. Total body water and the exchangeable hydrogen: II. A review of comparative data from animals based on isotope dilution and desiccation, with a report of new data from the rat. Am J Physiol. 1977;232:R60-5.
32. Bonora E, Del Prato S, Bonadonna RC, et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes. 1992;41:1151-9.
33. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23.
34. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38:1239-45.
35. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology. 1983;113:1511-8.
36. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823-5.
37. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995;8:894-901.
38. Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance: effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res. 1989;11:141-7.
39. Mak RH, Bettinelli A, Turner C, Haycock GB, Chantler C. The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab. 1985;60:229-33.
40. Manco M, Calvani M, Mingrone G. How to consider low serum vitamin D as risk factor for insulin resistance? Am J Clin Nutr. 2004;80:1450-51.
41. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J Clin Endocrinol Metab. 2001;86:1212-21.
42. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest. 1997;100:1166-73.
43. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age: European Group for the Study of Insulin Resistance (EGIR). Diabetes. 1996;45:947-53.
44. Fliser D, Stefanski A, Franck E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest. 1997;27:629-33.
45. Calvani M, Scarfone A, Granato L, et al. Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes. 2004;53:939-47.
46. Rosa G, Manco M, Vega N, et al. Decreased muscle acetylcoenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects. Obes Res. 2003;11:1306-12.
47. Mingrone G, Rosa G, Greco AV, et al. Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis. 2003;170:155-61.
48. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52:1098-103.
49. Rosa G, Di Rocco P, Manco M, et al. Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients. Obes Res. 2003;11:176-82.
50. Mingrone G, Rosa G, Di Rocco P, et al. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord. 2002;26: 1165-72.
51. Manco M, Mingrone G, Greco AV, et al. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism. 2000;49:220-4.
52. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986;1:187-92.
53. Marceau P, Biron S, Lebel S, et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg. 2002;6:690-8.
54. Zemel MB, Shi H, Greer B, DiRienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;4: 1132-8.
55. McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses. 2003;61:535-42.
56. Zemel MB. Mechanisms of dairy modulation of adiposity J. Nutr. 2003;133:252-6.
57. Shi H, DiRienzo D, Zemel MB. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J. 2001;15:291-3.
58. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index: the 5th Tromso study. Eur J Endocrinol. 2004;151:167-72.
59. Kumar S, Olukoga AO, Gordon C, et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf). 1994;40:47-53.
60. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf). 1992;37:147-55.
61. Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A, DeFronzo RA. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest. 1985;75: 1037-44.